Evidence map›Paper›PMID 40006754›Full record

ArticleVaccines2025

Correction: Patel et al. Development and Characterization of an In Vitro Cell-Based Assay to Predict Potency of mRNA-LNP-Based Vaccines.

Nisarg Patel, Zach Davis, Carl Hofmann, Josef Vlasak, John W Loughney, Pete DePhillips, Malini Mukherjee

Abstract readPublished Erratum
In one paragraph

Article in Vaccines, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

7 authors.

Nisarg PatelAnalytical Research & Development, Merck & Co., Inc., 770 Sumneytown Pike, West Point, PA 19486, USA.ORCID 0009-0005-7850-7420
Zach DavisAnalytical Research & Development, Merck & Co., Inc., 770 Sumneytown Pike, West Point, PA 19486, USA.
Carl HofmannAnalytical Research & Development, Merck & Co., Inc., 770 Sumneytown Pike, West Point, PA 19486, USA.
Josef VlasakAnalytical Research & Development, Merck & Co., Inc., 770 Sumneytown Pike, West Point, PA 19486, USA.
John W LoughneyAnalytical Research & Development, Merck & Co., Inc., 770 Sumneytown Pike, West Point, PA 19486, USA.
Pete DePhillipsAnalytical Research & Development, Merck & Co., Inc., 770 Sumneytown Pike, West Point, PA 19486, USA.
Malini MukherjeeAnalytical Research & Development, Merck & Co., Inc., 770 Sumneytown Pike, West Point, PA 19486, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The authors would like to make the following corrections to this published paper [...].

Identifiers

PMID40006754
PMCPMC11860595

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.